Weight LossNCT05540314
Robotic Bariatric Database (RBD) Collaborative
An observational study of Weight Loss and Obesity, run by Methodist Health System at 1 site in United States.
Trial summary
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Weight Loss, Obesity
- What is being tested?
- robotic bariatric surgery
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Aug 2022to 11 Aug 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Adult, Older adult
Study population: 3. Undergone robotic bariatric surgery between January 2018 and December 2019
Who may be able to join
- > 18 years of age
- Eligible for or have undergone robotic bariatric surgery per the treating physician
- Undergone robotic bariatric surgery between January 2018 and December 2019
Who cannot join
- Do not meet the Study Inclusion Criteria l
Trial locations and contacts
1 site in 1 country.
United States1 site
Methodist Charlton Medical Center
Dallas, Texas, 75237
About this study
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. In 1991, the National Institutes of Health Conference Statement on Gastrointestinal Surgery for Severe Obesity developed a consensus stating that bariatric surgery was the most effective treatment for obesity since it is associated with good long-term results in terms of weight loss, glycemic control and decreased mortality.
To collect and store clinical data related to the treatment outcomes of robotic bariatric surgery in order to develop an evidence base such that physicians can provide the best possible care to patients undergoing surgical weight loss interventions.
Read the detailed description
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss.
- Conditions
- Weight Loss, Obesity
- Being tested
- robotic bariatric surgery
- Medical subject headings
- Weight Loss, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
robotic bariatric surgeryProcedure or surgery
robotic bariatric surgery
| Study group | Role | What they receive |
|---|---|---|
| Subjects that have undergone robotic bariatric surgery | Subjects that have undergone robotic bariatric surgery between January 2018 and December 2019 Receives: Procedure: robotic bariatric surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Date of Birth
mm/dd/yyyy
Measured: January 2018- December2019
Principal Operative Procedure is an Initial Primary Metabolic or Bariatric Procedure
Yes or No
Measured: January 2018- December 2019
Patient has a history of metabolic or bariatric surgery
Yes or No
Measured: January 2018- December 2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2022
- Study start10 Aug 2022
- Primary completion10 Aug 2023
- Study completion11 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weight LossStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Methodist Health System
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sachin S . Kukreja, MD, Principal investigator, Methodist Health System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05540314
- Sponsor's protocol ID
- 001.WMP.2022.D
- Status last verified
- May 2026
- First submitted
- 12 Sep 2022
- Last updated
- 10 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Robotic Bariatric Database (RBD) Collaborative
- ClinicalTrials.gov ID
- NCT05540314
- Acronym / sponsor ID
- 001.WMP.2022.D
- Conditions
- Weight Loss, Obesity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Methodist Health SystemUniversity, hospital or other
- Study start
- 10 Aug 2022 (actual)
- Primary completion
- 10 Aug 2023 (actual)
- Study completion
- 11 Aug 2023 (actual)
- First posted
- 14 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss. In 1991, the National Institutes of Health Conference Statement on Gastrointestinal Surgery for Severe Obesity developed a consensus stating that bariatric surgery was the most effective treatment for obesity since it is associated with good long-term results in terms of weight loss, glycemic control and decreased mortality.
To collect and store clinical data related to the treatment outcomes of robotic bariatric surgery in order to develop an evidence base such that physicians can provide the best possible care to patients undergoing surgical weight loss interventions.
Detailed description
With increased prevalence of obesity in the general population over the past 30 years, researchers have been focused on the development of new treatment options to achieve long-lasting weight loss.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Subjects that have undergone robotic bariatric surgery | – | Procedure: robotic bariatric surgerySubjects that have undergone robotic bariatric surgery between January 2018 and December 2019 |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- 3. Undergone robotic bariatric surgery between January 2018 and December 2019
Key inclusion criteria (3 listed)
- > 18 years of age
- Eligible for or have undergone robotic bariatric surgery per the treating physician
- Undergone robotic bariatric surgery between January 2018 and December 2019
Key exclusion criteria (1 listed)
- Do not meet the Study Inclusion Criteria l
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| robotic bariatric surgeryrobotic bariatric surgery | Procedure or surgery | Subjects that have undergone robotic bariatric surgery |
Primary outcome
Date of Birth
Time frame: January 2018- December2019
mm/dd/yyyy
Principal Operative Procedure is an Initial Primary Metabolic or Bariatric Procedure
Time frame: January 2018- December 2019
Yes or No
Patient has a history of metabolic or bariatric surgery
Time frame: January 2018- December 2019
Yes or No
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Weight Loss
Recruiting
Preserving Muscle Mass During Incretin-Induced Weight Loss
Obesity (BMI > 35)
Active, not recruiting
Healthy Living After Knee Replacement
Arthroplasty, Overweight and Obesity
Not yet recruitingPhase 4
Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s
Obesity & Overweight, Cardiometabolic Health Indicators
Not yet recruitingPhase 2
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
Obesity, Overweight
Active, not recruiting
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
Severe Acute Malnutrition, Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sachin S . Kukreja, MD principal investigator
Methodist Health System
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Weight Loss and Obesity, run by Methodist Health System at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Date of Birth (time frame: January 2018- December2019). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.